Fatigue News and Research

RSS

Association of self-reported chronic fatigue and retinal microcirculation in post-COVID-19 syndrome patients

Researchers investigated the potential association between self-reported chronic fatigue and retinal microcirculation among post-COVID-19 syndrome patients.

27 Sep 2022

What is the impact of SARS-CoV-2 infection on semen parameters and sex hormones?

A new study aimed to systematically review studies investigating sex hormones and semen parameters in COVID-19 patients to provide a better understanding and treatment approach.

27 Sep 2022

What are the neuropsychiatric effects of SARS-CoV-2 infection?

Researchers investigated cognitive deficits associated with acute SARS-CoV-2 infection.

27 Sep 2022

COVID-19 can cause long-term lung damage to children and teens

In a recent study published in the Radiology journal, researchers in Germany assessed the pulmonary dysfunction observed after pediatric coronavirus disease 2019 (COVID-19).

27 Sep 2022

Study finds remdesivir-resistant version of COVID-19 in renal transplant recipients

Recent studies have shown that patients with weakened immune systems—which enables the virus that causes COVID-19 to remain longer in the body, copy itself, and continually change—may enable the development of new, slightly different versions of the virus (variants).

26 Sep 2022

Researchers explore neurological manifestations among long COVID patients

In a new study, researchers assessed the long-term neurological sequelae in the post-acute phase of coronavirus disease 2019 (COVID-19) or long COVD.

26 Sep 2022

Is covid ‘under control’ in the US? Experts say yes

President Joe Biden caused a stir in a “60 Minutes” interview on Sept. 18 when he declared that the covid-19 pandemic is over.

26 Sep 2022

Long-term follow-up of young people with COVID-19 vaccine myocarditis

In a recent study, researchers surveyed a comprehensive range of outcomes in patients diagnosed with myocarditis after COVID-19 vaccination in the United States.

26 Sep 2022

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

In a recent study posted to the medRxiv* preprint server, researchers in the United States described the safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), tested in PREVENT-19 — a phase 3, randomized, placebo-controlled, observer-blinded trial among 12- to 17-year-old adolescents in the United States (U.S).

25 Sep 2022

World Sepsis Month: Increasing Sepsis Awareness, Patient Support, and Improving Survivor Outcomes

As part of Sepsis Awareness Month, celebrated annually in September, News Medical Speaks to Dr. Ron Daniels, founder, and chief executive of the UK Sepsis Trust, about the significance of sepsis awareness, support for patients, and improving outcomes for sepsis survivors.

23 Sep 2022

Uganda confirms seven cases of Ebola and one death

Health authorities in Uganda have recently announced an Ebola Virus Disease outbreak in Mubende District, Uganda.

22 Sep 2022

Most people infected with SARS-CoV2 recover within 12 months, study finds

A McMaster University-led study has found that most people infected with the SARS-CoV2 virus recover within 12 months, irrespective of the severity.

22 Sep 2022

Why fatigue from long COVID goes beyond simply feeling tired

In a recent study posted to the medRxiv* preprint server, researchers in the Netherlands examined the role of inflammatory genes, cytotoxic T-lymphocytes (CD8+ T cells), and pro-inflammatory cytokines in long-lasting severe fatigue experienced by a large number of coronavirus disease 2019 (COVID-19) patients.

21 Sep 2022

What are the 2-year health outcomes among patients hospitalized for COVID-19 in China?

A recent study assessed the dynamic trajectory of COVID-19 symptom burden as well as symptom persistence in those who survived SARS-CoV-2 infection for two years after being discharged from hospitals.

20 Sep 2022

Neutralizing antibody responses, breakthrough SARS-CoV-2 infections, and symptoms after booster BNT162b2 COVID-19 vaccinations

A new study evaluated neutralizing antibody (nAb) responses against the SARS-CoV-2 Omicron variant induced by booster vaccination with Pfizer-BioNTech’s BNT162b2 messenger ribonucleic acid vaccine.

20 Sep 2022

Monkeypox infection in a smallpox-vaccinated patient

In a recent study published in the Emerging Infectious Diseases journal, researchers at Madigan Army Medical Center assessed the characteristics of monkeypox infection in a patient vaccinated against smallpox.

20 Sep 2022

Study estimates 18 million Americans have long-COVID

In a recent study posted to the medRxiv* preprint server, researchers evaluated the prevalence, risk factors, and impact of post-coronavirus disease (COVID) conditions (PCC) or long COVID on daily activities among adults residing in the United States (US).

19 Sep 2022

Milken Institute and ATF announce new Request for Proposals to advance understanding of sarcoidosis

The Milken Institute Center for Strategic Philanthropy, in partnership with the Ann Theodore Foundation (ATF), is pleased to announce a new Request for Proposals (RFP) focused on understanding the underlying biology of sarcoidosis, an immune dysregulation condition.

19 Sep 2022

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Early intervention with rituximab, a drug used in the treatment of rheumatoid arthritis (RA), can reduce the risk of deterioration in myasthenia gravis, an autoimmune disease that causes loss of muscle control.

19 Sep 2022

Vaccines used to prevent monkeypox

A new review published in The Lancet Infectious Diseases aimed to describe the efficacy of vaccinia virus-based smallpox vaccines against the current monkeypox outbreak.

18 Sep 2022

Fatigue News and Research

Association of self-reported chronic fatigue and retinal microcirculation in post-COVID-19 syndrome patients

What is the impact of SARS-CoV-2 infection on semen parameters and sex hormones?

What are the neuropsychiatric effects of SARS-CoV-2 infection?

COVID-19 can cause long-term lung damage to children and teens

Study finds remdesivir-resistant version of COVID-19 in renal transplant recipients

Researchers explore neurological manifestations among long COVID patients

Is covid ‘under control’ in the US? Experts say yes

Long-term follow-up of young people with COVID-19 vaccine myocarditis

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

World Sepsis Month: Increasing Sepsis Awareness, Patient Support, and Improving Survivor Outcomes

Uganda confirms seven cases of Ebola and one death

Most people infected with SARS-CoV2 recover within 12 months, study finds

Why fatigue from long COVID goes beyond simply feeling tired

What are the 2-year health outcomes among patients hospitalized for COVID-19 in China?

Neutralizing antibody responses, breakthrough SARS-CoV-2 infections, and symptoms after booster BNT162b2 COVID-19 vaccinations

Monkeypox infection in a smallpox-vaccinated patient

Study estimates 18 million Americans have long-COVID

Milken Institute and ATF announce new Request for Proposals to advance understanding of sarcoidosis

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Vaccines used to prevent monkeypox

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News